secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIVEPERSON INC (LPSN)
CIK:        0001102993
Form:       8-K
Filed at:   2023-03-15T23:59:59+00:00
Accession:  0001102993-23-000014
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LivePerson Q4 revenue $122.5M, net loss $41.7M; WildHealth Medicare suspension impacts results
--------------------------------------------------------------------------------

- Revenue $122.5M (-1% YoY); business ops revenue $113.0M, consumer $9.4M.
- Net loss $41.7M ($0.55/share) vs $49.9M ($0.70) prior year; adjusted EBITDA loss $5.2M.
- WildHealth Medicare reimbursement suspended; company took reserve for Q4 2022 revenue, causing guidance miss.
- Board elected to pay 2022 bonuses in cash instead of stock, reducing stock-based comp add-back by $9.2M.
- B2B Core expects double-digit adjusted EBITDA margins and positive free cash flow starting Q2 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1102993/000110299323000014/0001102993-23-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1102993/000110299323000014/lpsn-20230315.htm
  HTML page:      https://secwatch.observer/filing/0001102993-23-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer